Last year, the researchers behind the CLOTS 3 trial showed that intermittent pneumatic compression (IPC) sleeves reduced the risk of deep vein thrombosis (DVT) and improved survival in immobile patients with stroke.
One in five stroke survivors are left with partial or total loss of vision to one side following a stroke. The condition is called hemianopia, and can severely affect a stroke survivor's quality of life.
The aim of this research is to develop and test a simple yet widely-applicable outcome measure for evaluating cognitive rehabilitation after stroke. Consultation with patients and carers will shape the design and content of the measure.
Funded by the European Union (EU), a new international study called PROOF will investigate whether high-dose oxygen therapy can reduce the effects of stroke.
The Stroke Association is a member of the Stroke Alliance For Europe (SAFE), which will work on communication of information about the PROOF trial to non-clinical audiences.
Presented at the International Stroke Conference 2016, the final results from the PISTE trial (Pragmatic Ischaemic Stroke Thrombectomy Evaluation) add new evidence for the effectiveness of mechanical clot retri
The effect of blood pigments on brain inflammation and survival of nerve cells.
Stroke survivors often have very individual hopes for the future, in terms of the goals they would like to achieve. This research will develop and test a Goal setting and Action Planning (G-AP) approach to achieving personal goals through community rehabilitation.
Torpor is a natural state of reduced energy use and body temperature. This research will look at the effect of torpor on brain activity and function, and the amount of brain damage caused by ischaemic stroke.
This project will develop a special therapy area within ‘Second Life’, an existing virtual reality world on the internet. It will be protected so that only other people with aphasia and specially trained support workers can take part.
Cerebral small vessel disease (SVD) is usually associated with high blood pressure, and causes 20% of all strokes. It is the main cause of cognitive changes and dementia associated with stroke. Behavioural symptoms such as apathy are also common in patients with SVD.